Submitted by Anonymous (not verified) on 10 January 2025 - 16:29
Human medicines European public assessment report (EPAR): PreHevbri, hepatitis B surface antigen, Date of authorisation: 25/04/2022, Revision: 3, Status: Withdrawn
Source:
Human medicines European public assessment report (EPAR): PreHevbri, hepatitis B surface antigen, Date of authorisation: 25/04/2022, Revision: 3, Status: Withdrawn